Effect of the Angiotensin-converting Enzyme Inhibitor Enalapril on Post-transplant Erythrocytosis
この文献の参照には次のURLをご利用ください : https://ir.lib.hiroshima-u.ac.jp/00037803
ID | 37803 |
本文ファイル | |
著者 |
Marubayashi, Seiji
Yamamoto, Hiroyuki
Shibata, Satoshi
Fudaba, Yasuhiro
Fukuma, Kazuyuki
Okada, Kazuro
Ikeda, Masahiro
Maeda, Takashi
Oshiro, Yoshio
Dohi, Kiyohiko
|
キーワード | Erythrocytosis
Renal transplantation
Angiotensin converting enzyme inhibitor
|
NDC |
医学
|
抄録(英) | Post-transplant erythrocytosis (PTE) is increasingly recognized as a complication of kidney transplantation. In this study we report the effect of the angiotesin-converting enzyme (ACE) inhibitor enalapril on hematocrit (Ht) and erythropoietin in four patients with PTE. Four renal allograft recipients with Ht greater than 51 % were studied. Treatment was initiated with enalapril administered orally at a dose of 2.5 mg/day. All the patients had an increase of hemoglobin (Hb) (17.7 ± 0.64 g/dl), Ht (54.5 ± 1.29 %) and red blood cell count (REC) (584 ± 19.2 × 10⁴/μl). All patients responded to enalapril in 8 weeks with a significant decrease of Hb, Ht, and REC. In one patient, the downward trend was more rapid and sustained, and treatment had to be discontinued to prevent the development of anemia. Serum erythropoietin showed normal in all four patients and remained unchanged during the study, even after discontinuation of enalapril treatment. Serum creatinine remained relatively stable throughout the study. These results suggest that PTE may not be dependent upon circulating erythropoietin and that enalapril treatment may be an effective treatment of PTE without renal dysfunction.
|
掲載誌名 |
Hiroshima Journal of Medical Sciences
|
巻 | 47巻
|
号 | 3号
|
開始ページ | 121
|
終了ページ | 124
|
出版年月日 | 1998-09
|
出版者 | Hiroshima University Medical Press
|
ISSN | 0018-2052
|
NCID | |
言語 |
英語
|
NII資源タイプ |
紀要論文
|
広大資料タイプ |
学内刊行物(紀要等)
|
DCMIタイプ | text
|
フォーマット | application/pdf
|
著者版フラグ | publisher
|
部局名 |
医歯薬学総合研究科
|
他の一覧 |